Invesco EQV Emerging Markets All Cap Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-05-08 08:35:00 ET
Summary
- Class A shares underperformed the MSCI Emerging Markets Index.
- Stock selection in consumer discretionary, health care and financials detracted from relative results, as did an overweight in health care and underweights in financials and materials.
- During the quarter, we initiated four new positions and sold one position based on our EQV fundamentals.
- Regardless of the macroeconomic environment, we remain focused on applying our well-established, long-term, bottom-up EQV investment process that seeks to identify attractively valued, high quality growth companies.
...
Read the full article on Seeking Alpha
For further details see:
Invesco EQV Emerging Markets All Cap Fund Q1 2025 Commentary
P.T. Kalbe Farma ADR
NASDAQ: PTKFY
PTKFY Trading
0.0% G/L:
$12.30 Last:
100 Volume:
$12.30 Open:
